gimli
NEULANDLAB stock analysis context
NEULAND LAB. Stock Context for AI Screening
NEULAND LAB LTD. is a small-cap stock in Healthcare. This page summarizes key screening signals for NEULAND LAB., including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about NEULANDLABPrice
₹16,693.00
1M return
+10.79%
3M return
+32.09%
Market cap
₹21,416.95 cr
PE
58.84
ROE
+25.93%
RSI
60.51
Turnover
₹107.35 cr
Why it can matter in screens
- Momentum: NEULANDLAB is above 50DMA, above 200DMA; RSI is 60.51.
- Returns: 1M +10.79%, 3M +32.09%, 6M +0.57%.
- Liquidity: latest turnover is ₹107.35 cr.
- Valuation: PE 58.84, PB 11.43, ROE +25.93%, ROCE +33.52%.
- Growth: 3Y sales CAGR +15.81%, 3Y profit CAGR +59.72%.
Try these prompts
- Analyze NEULAND LAB. with valuation, momentum and industry peers
- Compare NEULANDLAB with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare NEULANDLAB with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.